Measurement ofBCR-ABL1transcripts on the International Scale in the United States: current status and best practices-Reference-Cited by-同舟云学术

Measurement ofBCR-ABL1transcripts on the International Scale in the United States: current status and best practices

Published:2016-07-14 Issue:1 Volume:58 Page:8-16
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Arora Ranjana,Press Richard D.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://tandfonline.com/doi/pdf/10.1080/10428194.2016.1190974

Reference46 articles.

1. The Biology of Chronic Myeloid Leukemia

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology – chronic myelogenous leukemia. NCCN Evidence Blocks; 2015. Version 1.2016 [Internet]. Available from: www.nccn.org.

3. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

4. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

5. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematologic complications after kidney and pancreas transplant in a patient with chronic myeloid leukemia;Cleveland Clinic Journal of Medicine;2024-03

2. Current Status of BCR::ABL1 Quantitative PCR Analysis in Korea (2022);Laboratory Medicine Online;2023-10-01

3. Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy;eLife;2023-04-28

4. Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis;Haematologica;2023-02-02

5. MOVER approximated CV: A tool for quantifying precision in ratiometric droplet digital PCR assays;Journal of Pharmaceutical and Biomedical Analysis;2022-04